Chemed Corp
(FRA:CXM)
€
545
5 (0.93%)
Market Cap: 8.30 Bil
Enterprise Value: 8.23 Bil
PE Ratio: 30.27
PB Ratio: 7.41
GF Score: 95/100 Chemed Corp at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021 / 02:20PM GMT
Release Date Price:
€390
(-1.52%)
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
(technical difficulty) services and managed care coverage universe. Today, we have Chemed Corporation in our next fireside chat.
With us today, we have Chemed CFO, Dave Williams, along with the CEO of VITAS and the EVP of Chemed, Nick Westfall. So welcome, gentlemen.
David P. Williams
Chemed Corporation - Executive VP & CFO
Thanks, Frank.
Nicholas Michael Westfall
VITAS Healthcare Corporation - CEO & President
Thanks, Frank. Great to be here.
Questions & Answers
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
Look, why don't we first start out, maybe at a high level here, kind of assessing and looking at and evaluating the regulatory and maybe the more -- maybe the policy backdrop for hospice today. We'll talk more about the payment updates and those kind
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot